NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02215980,STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS,https://clinicaltrials.gov/study/NCT02215980,,COMPLETED,"This protocol is a phase III multicenter, randomized, controlled study designed to assess the safety and the efficacy of standard schedule versus a new algoritm of dose reductions in elderly and unfit newly diagnosed Multiple Myeloma (MM) patients receiving lenalidomide plus steroids.",NO,Multiple Myeloma,DRUG: Lenalidomide|DRUG: Dexamethasone,"Event-free survival, Determine the Event-free survival defined as:

* Progression
* Death for any cause
* Discontinuation of lenalidomide therapy
* Occurrence of any haematological grade 4 or non-haematological grade 3-4 adverse events (AES), including Secondary Primary Malignancies (SPMs), 3 years","Progression-free survival (PFS), 5 years|Overall survival (OS), 5 years|Time to progression (TTP), 5 years|Overall response rate (ORR), 5 years|Time to response (TTR), 5 years|Duration of response (DOR), 5 years|Time to the next therapy (TNT), 5 years|Incidence of dose reduction and drug discontinuation, 5 years|Health care cost, 5 years|Correlation between tumor response and outcome with baseline prognostic factors, Analysis of tumor response and outcome stratification by prognostic factors, 5 years|Quality of life assessment (HRQOL), 5 years",,Fondazione EMN Italy Onlus,,ALL,OLDER_ADULT,PHASE3,210,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,RV-MM-PI-0752,2014-07,2022-07,2024-07-01,2014-08-13,,2024-07-22,"Fondazione EMN Italy Onlus, Torino, 10126, Italy",
